BlueRock Therapeutics Compagnie réclamée
BlueRock Therapeutics LP is a clinical stage cell therapy harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, bemdaneprocel (BRT-DA01) for the treatment of Parkinson’s disease and OpCT-001 for the treatment of primary photoreceptor diseases are clinical stage programs. BlueRock was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer. Our culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that we are all part of something bigger than ourselves.
Lire la suite
Involvement in exciting work alongside excellent colleagues.
Quelle est la meilleure partie de votre programme de rémunération?
Good base salary and bonus structure.
Qu’est-ce qui vous plaît le plus dans l’équipe de direction?
Communication, enthusiasm, representing our interests in discussions with Bayer.
Quelles sont les meilleures choses à propos de votre équipe?
Passion for our shared goals and the resulting team-first, get-it-done attitude.
Qu’est-ce qui est le plus positif à propos de la culture et de l’environnement de votre entreprise?
Culture of friendship on and off the clock. Social activities that exceed the bounds of work-sanctioned events, leading to stronger connections.
Other Employee Reviews for BlueRock Therapeutics
×